This study included 63 confirmed cases of malignant glioma patients which were analyzed for MGMT gene methylation and its protein expression to observe the impact of alkylating chemotherapeutic agent Temozolomide on the OS and PFS of the patients. This evidence concerns the gene MGMT and malignant glioma.